Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
25.41
+1.30 (5.39%)
Mar 27, 2026, 4:00 PM EDT
Market Cap2.92B +51.2%
Revenue (ttm)196.21M +0.7%
Net Income51.71M +16.8%
EPS0.48 +17.1%
Shares Out108.22M
PE Ratio56.15
Forward PEn/a
Dividend0.32 (1.26%)
Ex-Dividend Daten/a
Volume2,803,570
Average Volume1,471,057
Open23.72
Previous Close24.11
Day's Range23.66 - 25.55
52-Week Range14.46 - 28.93
Beta0.54
RSI66.30
Earnings DateApr 25, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 324
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2025, SHA:688163's revenue was 196.21 million, an increase of 0.66% compared to the previous year's 194.92 million. Earnings were 51.71 million, an increase of 16.76%.

Financial Statements